• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2026 ABC News
  • Wellness

Free at-home COVID testing program restarting as officials prepare for fall, winter season

1:02
FDA approves new COVID vaccines
Universal Images Group via Getty Images
ByMary Kekatos and Dr. Aditi Kantipuly
August 23, 2024, 5:36 PM

The federal government will restart its free at-home COVID tests program in September as officials prepare the country for the upcoming respiratory virus season.

Dawn O'Connell, assistant secretary for preparedness and response at the Department of Health and Human Services, said Friday that this is the seventh time the Biden-Harris administration has allowed Americans to order over-the-counter tests at no charge.

It's not clear when the website, COVID.gov/tests, will come back online. The website stopped accepting orders in early March.

Related Articles

MORE: What to know about the updated COVID vaccines coming this fall

"As families start to move indoors this fall and begin spending time with their loved ones, both very old and very young, they will once again have the opportunity to order up to four new COVID-19 tests free of charge and have them sent directly to their homes," O'Connell told reporters. "These tests will help keep families and their loved ones safe this fall and winter season."

She added that the tests will be able to detect infection from currently circulating variants.

A COVID-19 at home self-test kit.
Universal Images Group via Getty Images

During the same media briefing, federal officials said the summer uptick of COVID cases is not leading to a similar surge in hospitalizations and deaths as seen in previous years.

Dr. Mandy Cohen, director of the Centers for Disease Control and Prevention, said immunity from vaccination and previous COVID infection have helped limit the burden of COVID on the health care system.

"I do want to acknowledge that we continue to see a lot of COVID-19 activity across the country right now in tests coming back from labs," Cohen said, adding, "Circulating COVID disease is not translating into similar increases in emergency room visits and hospitalizations or deaths."

Cohen said the severity of COVID is starting to look similar to flu but noted that COVID is still more dangerous.

According to a federal forecast for the upcoming respiratory virus season, the U.S. can expect similar or slightly improved figures in terms of peak hospitalizations when looking at COVID, flu and RSV together, she said.

"We know that protection decreases over time, and certain groups continue to be at higher risk from COVID and other viruses and we need to continue to protect ourselves and our loved ones," Cohen said.

Related Articles

MORE: Where COVID cases are increasing in the US amid summer 'bump'

Officials also reiterated who should get vaccinated for COVID, flu and RSV ahead of the upcoming respiratory virus season.

For COVID-19 and flu, the CDC recommends that everyone ages 6 months and older receive a COVID and flu vaccine, including pregnant women. Cohen said individuals can receive both vaccines at the same time.

On Thursday, the FDA approved and granted emergency use authorization for updated COVID-19 vaccines from Pfizer-BioNTech and Moderna for the upcoming fall and winter season.

COVID-19 vaccine manufacturers told ABC News the vaccines are expected to be available in the coming week.

For RSV, all infants younger than 8 months old and infants between 8 months and 18 months who are high risk should get vaccinated. RSV vaccination is also recommended for pregnant women between 32 weeks and 36 weeks gestation as well as all adults ages 75 and older and adults between ages 60 and 74 who are at high risk.

In this Jan. 25, 2022 file photo pre-loaded syringes of the COVID-19 vaccine are ready for use in New Orleans.
Ted Jackson/AP, FILE

In addition to tests, O'Connell said Paxlovid, an antiviral drug used to treat COVID-19 infections for those at risk of hospitalization, will be available for free for individuals on Medicare and Medicaid as well as for those who are uninsured.

Beginning in 2025 and running through 2028, Pfizer, which manufactures Paxlovid, will take over the patient assistance program for individuals who are uninsured and underinsured, O'Connell said.

Additionally, Merck's patient assistance program will continue to administer Lagevrio, an antiviral used to treat patients in need of hospitalization from COVID-19, to those who are uninsured.

"Distributing at-home tests and securing access to treatments is an essential part of the Biden Harris administration's efforts to ensure that we are as prepared as possible for the upcoming fall and winter respiratory season," O'Connell said.

Up Next in Wellness—

Baby born at 22 weeks, 3 days goes home from hospital ahead of 1st birthday

May 15, 2026

What parents should know about talking to kids about hantavirus

May 13, 2026

American who survived hantavirus in 1993 outbreak describes her symptoms and recovery

May 12, 2026

3-year-old with rare disease helps raise $500K for inclusive playground

May 12, 2026

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2026 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2026 ABC News